Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
43 hedge funds and large institutions have $31.3M invested in Histogen Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
33% more capital invested
Capital invested by funds: $23.5M → $31.3M (+$7.78M)
5% more funds holding
Funds holding: 41 → 43 (+2)
3% less call options, than puts
Call options by funds: $1.33M | Put options by funds: $1.37M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$2.33M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.79M |
| 3 |
BlackRock
New York
|
+$807K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$715K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$346K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$792K |
| 2 |
Millennium Management
New York
|
-$572K |
| 3 |
Goldman Sachs
New York
|
-$232K |
| 4 |
KAH
Kathryn A. Hall
|
-$166K |
| 5 |
JRP
Jasper Ridge Partners
Menlo Park,
California
|
-$153K |
HSTO Hedge Fund Activity: Q1 2017 in Review
43 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2017, worth a combined $31.3M — up 33% from $23.5M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new HSTO positions and 5 closed out — a net gain of 6 holders — while 16 added to existing stakes and 10 trimmed.
The largest buyer was Putnam Investments, opening a new position worth an estimated $2.33M. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $792K sold.
- 43 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2017, up from 41 in Q4 2016.
- Funds reported $31.3M of Histogen Inc. Common Stock stock for Q1 2017, up 33% quarter-over-quarter.
- 11 funds opened new Histogen Inc. Common Stock positions in Q1 2017 and 5 closed out, a net change of +6 holders.
- The largest Histogen Inc. Common Stock buyer in Q1 2017 was Putnam Investments, an estimated $2.33M added.
- The largest Histogen Inc. Common Stock seller in Q1 2017 was Virtu KCG Holdings, an estimated $792K sold.
Based on aggregated 13F filings for Q1 2017.